BioPharma APAC

BioPharma Clinical Trials

ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors

Solid tumor has long been a challenge for CAR-T. Major obstacles include solid tumor heterogeneity, lack of tumor associated antigens as CAR-T targets, com...

January 25, 2022 | News

The Philippines Has Approved ReCOV For Phase II/III Clinical Trial

Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial ReCOV induced high levels of neutralizing ...

January 18, 2022 | News

China Based Gracell Biotechnologies Unveils Innovation Center in U.S.

As a pivotal part of Gracell's global strategy, the company is fully committed to expanding its operations in the U.S. to enhance and diversify its in-hous...

January 13, 2022 | News

Clario and XingImaging expand partnership to deliver PET imaging clinical trials in China

Clario, formerly ERT and Bioclinica, and XingImaging joined forces in 2018 to support multi-center clinical trials requiring PET for eligibility and drug e...

January 12, 2022 | News

CARsgen Announces CT041 CAR T-cell Product Candidate Granted RMAT Designation by the FDA

With the RMAT designation, CT041 enjoys all the benefits of Fast Track and Breakthrough Therapy designations including early and intensive FDA guidance on ...

January 11, 2022 | News

Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials

Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction ...

January 10, 2022 | News

Nuance Pharma acquires Sino Health

Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, tod...

January 07, 2022 | News

Calyxt Announces Pilot BioFactory™ Production System Now Operational

"I am proud of the effort our team and suppliers made to achieve this milestone on schedule, as it marks an important step in the scaling of our production...

January 07, 2022 | News

Study highlights Antengene's complementary focus on diseases with a higher prevalence in China

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and ...

January 03, 2022 | News

Ascletis Expands Ritonavir Oral Tablet Production

Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...

January 03, 2022 | News

Noorik Biopharmaceuticals announces contract for ambrisentan treatment of COVID-19

Noorik Biopharmaceuticals Ltd. ("Noorik"), a clinical-stage biopharmaceutical company repurposing micro-dose ambrisentan for the treatment of kidney, liver...

December 16, 2021 | News

Everest Medicines to treat Triple-Negative Breast Cancer in South Korea

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...

December 15, 2021 | News

WuXi AppTec Receives 2021 Global Customer Value Leadership Award

The Frost & Sullivan Best Practices Awards recognize companies at the forefront of their industries that consistently demonstrate leadership in innovat...

December 09, 2021 | News